BCAB — Bioatla Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapNeutral
- $145.16m
- -$32.96m
- $0.25m
- 28
- 33
- 55
- 32
Annual cashflow statement for Bioatla, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -29 | -29.9 | -35.9 | -95.4 |
| Depreciation | ||||
| Non-Cash Items | 3.52 | -4.48 | 1.87 | 24.4 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -10.7 | 23.8 | -3.36 | 7.42 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -35.3 | -9.64 | -36.3 | -62.2 |
| Capital Expenditures | -0.988 | -1.51 | -0.59 | -0.924 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.988 | -1.51 | -0.59 | -0.924 |
| Financing Cash Flow Items | 0.019 | -0.005 | 200 | -1.91 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 5.02 | 4 | 272 | 69.5 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -31.3 | -7.16 | 235 | 6.37 |